asparaginase

Type: Keyphrase

Name: asparaginase

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Jazz Pharmaceuticals Public Limited Company Presents at UBS Global Healthcare Conference, May-21-2013 09:30 AM

Ami Fadia - UBS Investment Bank, Research DivisionGood morning, everybody. Thanks for coming to the UBS Conference. I'm Ami Fadia. I cover mid-cap spec pharma stocks at UBS. It's my pleasure to have Kate, who is the CFO of Jazz Pharmaceuticals, to present. ... [Published Seeking Alpha - May 21 2013]

Entities: asparaginase, Xyrem, PRIALT

First reported May 15 2013 - Updated May 15 2013 - 1 reports

RJ Reynolds Tobacco Company

Patent Issued for Thermal Treatment Process for Tobacco Mate. . .

Patent Issued for Thermal Treatment Process for Tobacco MaterialsR. J. Reynolds Tobacco CompanyNewsRx.comBy a News Reporter-Staff News Editor at Life Science Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors ... [Published Equities.com - May 15 2013]

Entities: Tobacco, Smokeless Tobacco, Oxidation, RJ Reynolds Tobacco Company, Thermal Treatment

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events

SOURCE Jazz Pharmaceuticals plcDUBLINAn archived version of each audio webcast will be available for at least one week following each respective presentation on the Investors section of the company's website at www.jazzpharmaceuticals.com.About Jazz Pharmaceuticals ... [Published WVNS - May 14 2013]

Entities: Jazz Pharmaceuticals Inc, Erwinia Chrysanthemi, Fazaclo, PRIALT, ziconotide

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Jazz Pharmaceuticals Public Limited Management Discusses Q1 2013 Results - Earnings Call Transcript

Jazz Pharmaceuticals Public Limited (JAZZ) Q1 2013 Earnings Call May 7, 2013 4:30 PM ETOperatorWelcome to the Jazz Pharmaceuticals First Quarter 2013 Earnings Conference Call. Following an introduction from the company, we will open the call to questions. ... [Published Seeking Alpha - May 08 2013]

Entities: Xyrem, PRIALT, Narcolepsy, Jazz Pharmaceuticals Inc

First reported Mar 03 2013 - Updated Mar 03 2013 - 1 reports

Jazz Pharmaceuticals: Music To Our Ears

By Capital Traders Group : The biopharmaceutical industry is known for its volatility and frenzied state of ups and downs. But among chaos exists a company that has displayed consistent growth in recent years and will surely soar in the future. Jazz ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Mar 03 2013]

Entities: Jazz Pharmaceuticals Inc, Narcolepsy, Xyrem

First reported Feb 05 2013 - Updated Feb 06 2013 - 2 reports

Jazz Pharmaceuticals Inc

ERWINAZE (Asparaginase) Injection, Powder, Lyophilized, For Solution [Jazz Pharmaceuticals, Inc.]

Updated Date: Feb 5, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 06 2013]

Entities: asparaginase, Jazz Pharmaceuticals Inc

First reported Dec 05 2012 - Updated Dec 05 2012 - 1 reports

Jazz Pharma starts trial of IV administered Erwinaze in patients with ALL

Jazz Pharmaceuticals, a specialty biopharmaceutical company, has enrolled and dosed first patient in a clinical trial of Erwinaze (asparaginase Erwinia chrysanthemi) administered intravenously (IV) as an alternative method of administration to treat patients ... [Published PharmaBiz - Dec 05 2012]

Entities: asparaginase, Jazz Pharmaceuticals Inc, hypersensitivity, Escherichia Coli (E. Coli)

First reported Dec 04 2012 - Updated Dec 04 2012 - 1 reports

Jazz begins Erwinaze trial in acute lymphoblastic leukemia patients

Jazz Pharmaceuticals has initiated patient dosing in a clinical trial intravenously (IV) administering Erwinaze in acute lymphoblastic leukemia (ALL) patients hypersensitive to asparaginase therapy derived from E. coli. ... [Published PBR - News - Dec 04 2012]

Entities: Acute Lymphoblastic Leukemia, asparaginase, Jazz Pharmaceuticals Inc, Escherichia Coli (E. Coli), Clinical trials

Quotes

"The amounts of each ingredient of the heat-treated smokeless tobacco composition can vary, but in one embodiment, the composition comprises about 20 to about 60 dry weight percent of a tobacco material, about 20 to about 50 dry weight percent of one or more fillers, about 5 to about 20 dry weight percent of one or more binders, and about 1 to about 10 dry weight percent of one or more flavorants."

Patent Issued for Thermal Treatment Process for Tobacco Mate. . . [Published Equities.com - May 15 2013]

The abstract of the patent published by the U S Patent and Trademark Office states: "A reusable shipping container adapted to resist damage to the feet of the container and to allow the fork straps to be replaced if the fork straps or the feet are damage. The container can also easily be adapted to accommodate the use of pallet jacks without reducing the capacity of the container or increasing the weight of the container. The container is also adapted to easily receive dunnage required to protect the material being shipped in the container." The patent application was filed on July 6, 2009 (13/002,086). The full-text of the patent can be found at http://patft.uspto...

U.S. Patents Awarded to Inventors in Kentucky (May 13) [Published Equities.com - May 13 2013]

More Content

sort by: Date \| Relevance
Jazz Pharmaceuticals Public Limited Company Pre... [Published Seeking Alpha - May 21 2013]
Now Available: Jazz Pharmaceuticals plc (JAZZ) ... [Published Live-PR.com - May 21 2013]
Tackling Cancer: Leukemia's Biggest Current and... [Published Motley Fool Discussion Boards - May 19 2013]
Delivery system for cytotoxic drugs by bispecif... [Published PharmCast - May 19 2013]
Jazz Pharmaceuticals plc (JAZZ) - Pharmaceutica... [Published TransWorldNews - May 17 2013]
Patent Issued for Thermal Treatment Process for... [Published Equities.com - May 15 2013]
Jazz Pharma Posts Higher Y/Y Earnings Zacks [Published Yahoo! Finance - May 14 2013]
Jazz Pharmaceuticals Announces Participation In... [Published SPi World News - May 14 2013]
Jazz Pharmaceuticals Announces Participation In... [Published WVNS - May 14 2013]
U.S. Patents Awarded to Inventors in Kentucky (... [Published Equities.com - May 13 2013]
Jazz Pharmaceuticals Public Limited Management ... [Published Seeking Alpha - May 08 2013]
JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 20... [Published Barchart - May 07 2013]
JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 20... [Published ADVFN UK - May 07 2013]
NYSE EURONEXT: ERYTECH celebrates successful li... [Published 4 Traders - May 07 2013]
ERYTECH celebrates successful listing on NYSE E... [Published NYSE Euronext - May 07 2013]
Gastrin releasing peptide compounds [Published PharmCast - Apr 30 2013]
Jazz Pharmaceuticals plc (JAZZ) - Financial and... [Published TransWorldNews - Apr 21 2013]
ERYTECH Announces its IPO on NYSE Euronext Pari... [Published 4 Traders - Apr 18 2013]
Jazz Pharmaceuticals: Music To Our Ears [Published Healthcare Sector and Stocks Analysis from Seek ... - Mar 03 2013]
ERWINAZE (Asparaginase) Injection, Powder, Lyop... [Published DailyMed Drug Label Updates for the last seven ... - Feb 06 2013]
ERWINAZE (Asparaginase) Injection, Powder, Lyop... [Published DailyMed Drug Label Updates for the last seven ... - Feb 05 2013]
AIBioTech™ Announces a New Test to Assess L-asp... [Published EON Health & Medicine - Feb 04 2013]
AIBioTech™ Announces a New Test to Assess L-asp... [Published Business Wire Science: Science News - Feb 04 2013]
AIBioTech™ Announces a New Test to Assess L-asp... [Published Business Wire Health News - Feb 04 2013]
Lundbeck to divest a portfolio of non-core prod... [Published GlobeNewswire - Dec 14 2012]
Jazz Pharmaceuticals Announces Presentation Of ... [Published PR Newswire: Health - Dec 10 2012]
Anti-cocaine compositions and treatment [Published PharmCast - Dec 09 2012]
Jazz Pharma starts trial of IV administered Erw... [Published PharmaBiz - Dec 05 2012]
Jazz begins Erwinaze trial in acute lymphoblast... [Published PBR - News - Dec 04 2012]
Jazz Pharmaceuticals Begins Clinical Trial of I... [Published PR Newswire: Health - Dec 03 2012]